Overview

Seattle Cancer Care Alliance provides comprehensive, leading-edge expertise in diagnosing and treating Myelodysplastic Syndrome (MDS), a group of diseases that affect the blood-forming stem cells. SCCA was formed, in part, to bring promising new treatments to patients faster. For people with MDS, this means more treatment options at SCCA than might be found elsewhere, including participating in one of many clinical trials conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine. 

 

If your condition requires a bone-marrow transplant, you should know that the Fred Hutchinson Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutchinson Center pioneered the use of bone-marrow transplants as a treatment for blood diseases over 40 years ago. Since then thousands of patients with MDS have come from around the world to receive bone-marrow transplants at SCCA. Bone-marrow transplants have transformed MDS and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.

Our Expertise

Find out why SCCA is one of the best places to come for treatment for myelodysplastic syndrome.

Our Doctors

Our doctors are members of Fred Hutchinson Cancer Research Center and UW Medicine and are committed to providing the best possible care for myelodysplactic syndrome patients who come to SCCA for treatment.

Treatment Options

Regardless of the stage of your illness, the unsurpassed expertise of our physicians makes SCCA the ideal treatment center for myelodysplastic syndrome (MDS).

What to Expect

Receiving a diagnosis for myelodysplastic syndrome leads to many questions. SCCA physicians and staff provide compassionate care and support during your course of treatment so you will always know what to expect.

Participate in a Study

Participation in a clinical study is an option that many MDS patients choose when they come to SCCA for treatment. Find out why.

Myelodysplastic Syndrome Facts

Learn about the risk factors and symptoms of myelodysplastic syndrome, how it is diagnosed and how its stages are determined.

Patient Support

Because treatment for Myelodysplastic Syndrome (MDS) isn't easy, special support for patients is essential. SCCA has several programs, classes, and services to assist patients and their families.

Resources

The more you know about your disease, the more empowered you'll feel. This list of reputable sources about Myelodysplastic Syndrome (MDS) makes gathering information easy.

Seattle Cancer Care Alliance
825 Eastlake Ave. E, P.O. Box 19023, Seattle, WA 98109-1023
(206) 288-SCCA (7222), contactus@seattlecca.org